The following is a glossary of a number of the terms and acronyms which can be found within this document:
ABC
Anti-Bribery and Anti-Corruption
ANZ
Australia and New Zealand
APM
Alternative Performance Measures
BEPS
Base Erosion Profit Shifting
Bioequivalence
The demonstration that the proposed formulation has the same biological effects as the pioneer product to which it is being compared. This is usually demonstrated by comparing blood concentrations of the active over time, but can be compared using a clinical endpoint (e.g. lowering of a worm count) for drugs that are not absorbed or for which blood levels cannot be determined
CAGR
Compound Annual Growth Rate
CAP
Companion Animal Products
Capex
Capital Expenditure
CDGP
Canine Diabetes Genetics Partnership
CER
Constant Exchange Rate
CMO
Contract Manufacturing Organisation
Code
UK Corporate Governance Code 2018
CRM
Client Relationship Management
CSOP
Company Share Option Plan
CSR
Corporate Social Responsibility
CVMP
Committee for Veterinary Medicinal Products
Dechra Values or Values
Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition
DPM&S
Dechra Pharmaceuticals Manufacturing and Supply
DSC
Dechra Service Center
DVP
Dechra Veterinary Products
DVP EU
Dechra Veterinary Products EU or Dechra Veterinary Products Europe
DVP International
Dechra Veterinary Products International
DVP NA
Dechra Veterinary Products North America
DVP US
Dechra Veterinary Products US
EBIT
Earnings before interest and tax. This is the same as operating profit
EBITDA
Earnings before interest, tax, depreciation and amortisation
EMA
European Medicines Agency
ERP
Enterprise Resource Planning
ESG
Environmental, Social and Governance
ESPP
Employee Stock Purchase Plan
EU Pharmaceuticals
European Pharmaceuticals Segment comprising DVP EU, DVP International and DPM&S
Executive Directors
The Executive Directors of the Company, currently Ian Page, Paul Sandland and Tony Griffin
FAP
Food producing Animal Products
FDA
US Food and Drug Administration
FRC
Financial Reporting Council
FRS
Financial Reporting Standards
FTSE
Companies listed on the London Stock Exchange
FTSE 250/350 Index
An index comprising the 101st to 350th largest companies listed on the London Stock Exchange in terms of their market capitalisation
GAAP
Generally Accepted Accounting Practices
GDPR
General Data Protection Regulation
GMP
Good Manufacturing Practices
GRT
Gross Registered Tonnage
IAS
International Accounting Standards
IFRSs
International Financial Reporting Standards
KPI
Key Performance Indicator
Leverage
The ratio of Net Debt to underlying EBITDA
LIBOR
The London Inter-Bank Offered Rate
LTAFR
Lost Time Accident Frequency Rate
LTIP
Long Term Incentive Plan
Non-Executive Directors
The Non-Executive Directors of the Company, currently Tony Rice, Lisa Bright, Julian Heslop, Lawson Macartney, Ishbel Macpherson and Alison Platt
NA Pharmaceuticals
North American Pharmaceuticals Segment comprising DVP US, Canada and Dechra-Brovel
OECD
The Organisation for Economic Cooperation and Development
Ordinary Shares
An ordinary share of 1 pence in the share capital of the Company
Oracle Programme
Enterprise Resources Planning (ERP) software
PDRA
Dechra’s Product Development and Regulatory Affairs team
PPE
Personal Protective Equipment
POMs
Prescription Only Medicines
Qualifying LTIP Award
Qualifying LTIP Awards comprises a CSOP option and an ordinary nil-cost LTIP award, with the ordinary award scaled back at exercise to take account of any gain made on exercise of the CSOP option
R&D
Research and Development
RCF
Revolving Credit Facility
RIDDOR
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations
Rights Issue
The three for ten rights issue of 20,040,653 shares, details of which are set out in the prospectus of the Company dated 25 April 2012
ROCE
Return On Capital Employed
SASB
Sustainability Accounting Standards Board
SAYE
Save As You Earn Share Scheme
SDG
United Nations Sustainable Development Goals
SG&A
Selling, General and Administrative Expenses
S&OP
Sales & Operations Planning
SPC
Summary of Product Characteristics
TCFD
Taskforce for Climate-related Financial Disclosures
TGA
Therapeutic Goods Administration
TSR
Total Shareholder Return